Ka Jun, Jin Suk-Won
Cell Logistics Research Center and School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea.
Yale Cardiovascular Research Center and Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
J Lipid Atheroscler. 2021 Jan;10(1):42-56. doi: 10.12997/jla.2021.10.1.42. Epub 2020 Dec 22.
Dyslipidemia related diseases such as hyperlipidemia and atherosclerosis are the leading cause of death in humans. While cellular and molecular basis on the pathophysiology of dyslipidemia has been extensively investigated over decades, we still lack comprehensive understanding on the etiology of dyslipidemia due to the complexity and the innate multimodality of the diseases. While mouse has been the model organism of choice to investigate the pathophysiology of human dyslipidemia, zebrafish, a small freshwater fish which has traditionally used to study vertebrate development, has recently emerged as an alternative model organism. In this review, we will provide comprehensive perspective on zebrafish as a model organism for human dyslipidemia; we will discuss the attributes of zebrafish as a model, and compare the lipid metabolism in zebrafish and humans. In addition, we will summarize current landscape of zebrafish-based dyslipidemia research.
血脂异常相关疾病,如高脂血症和动脉粥样硬化,是人类死亡的主要原因。尽管数十年来人们对血脂异常病理生理学的细胞和分子基础进行了广泛研究,但由于这些疾病的复杂性和固有的多模态性,我们对血脂异常的病因仍缺乏全面了解。虽然小鼠一直是研究人类血脂异常病理生理学的首选模式生物,但斑马鱼,一种传统上用于研究脊椎动物发育的小型淡水鱼,最近已成为另一种模式生物。在这篇综述中,我们将全面介绍斑马鱼作为人类血脂异常模式生物的情况;我们将讨论斑马鱼作为模式生物的特性,并比较斑马鱼和人类的脂质代谢。此外,我们将总结基于斑马鱼的血脂异常研究的现状。